Skip to content

Evaluation on Effects of a Combined Therapeutic Plan with Massage, Herbal Medicine Iontophoresis and Acupoint Injection on lumbar disc protrusion

Evaluation on Effects of a Combined Therapeutic Plan with Massage, Herbal Medicine Iontophoresis and Acupoint Injection on lumbar disc protrusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-14005609
Enrollment
Unknown
Registered
2014-08-25
Start date
2014-12-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar disc protrusion

Interventions

1:Acupoint injection
2:Herbal medicine iontophoresis
4:muscle injection with cobamamide

Sponsors

Eye Hospital, China academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with lumbar disc protrusion according to criteria; 2. Male or female participants with age ranged from 16 to 65; 3. Subjects without surgery history involving lumbar disc; 4. Patients will not accept other treatment on lumbar disc protrusion while engaging in this study; 5. Subjects who signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 16 and older than 65; 2. Patients without improvement after standard non-surgical therapy for 6 months; 3. Subjects have engaged in other clinical study in recent 3 months; 4. Patients suddenly suffered decreased myodynamia and with myodynamia less than III; 5. Subjects manifested with syndromes caused by cauda equine compression; 6. Patients possess indexes for surgery like prolapsed of lumbar disc; 7. Subjects underwent serious injury or surgery involving lumbar disc; 8. Pregnant women or willing to be conceived in short time; 9. Subjects with gastric ulcer, duodenal ulcer or gastrointestinal inflammation; 10. Patients complicated with defects in liver, kidney, cerebral vascular, hemopoietic system, endocrine system, neural system or with tuberculosis, vertebral deformity, malignant tumor, psychosis.

Design outcomes

Primary

MeasureTime frame
visual analogue scale (VAS);Japanese Orthopedic Association (JOA) Index;Oswestry Dability Index (ODI);SF-36 index;

Countries

China

Contacts

Public ContactWang JinRong
Drwangjinrong@126.com+86 010-68688877-681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026